HomeSABS • NASDAQ
add
SAB Biotherapeutics Inc
Previous close
$3.84
Day range
$3.80 - $3.95
Year range
$1.00 - $6.60
Market cap
184.71M USD
Avg Volume
295.66K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 12.19M | 12.58% |
Net income | 45.45M | 539.11% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -11.91M | -15.19% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 110.88M | 264.73% |
Total assets | 183.45M | 241.00% |
Total liabilities | 18.37M | 8.76% |
Total equity | 165.07M | — |
Shares outstanding | 47.61M | — |
Price to book | 1.10 | — |
Return on assets | -29.68% | — |
Return on capital | -33.42% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 45.45M | 539.11% |
Cash from operations | -13.05M | -107.41% |
Cash from investing | -129.87M | -11,167.05% |
Cash from financing | 168.69M | 25,123.21% |
Net change in cash | 25.73M | 418.82% |
Free cash flow | -5.10M | -62.67% |
About
Founded
2014
Headquarters
Website
Employees
63
